NanJing Pharmaceutical Company Limited Goodwill

NanJing Pharmaceutical Company Limited (600713.SS) currently reports a goodwill of $63M as of June 2026. That compares with $72M in the prior-year period — down 12.4% year over year. Use the charts on this page to explore NanJing Pharmaceutical Company Limited's goodwill history and peer comparisons.

NanJing Pharmaceutical Company Limited's goodwill decreased from $72M to $63M — a 12.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NanJing Pharmaceutical Company Limited reported $63M in goodwill as of June 2026. That compares with $72M in the prior-year period — down 12.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NanJing Pharmaceutical Company Limited, and consider following 600713.SS for alerts when major investors trade the stock.